Pharmaceutical Industry Today

Global Inhalers Market Projected to Expand Steadily Through 2031 With 5.3% CAGR

The global inhalers market is set for steady growth through 2031, with a projected CAGR of 5.3%. While traditional metered dose inhalers (MDIs) continue to dominate, dry powder inhalers (DPIs) and digital inhalers are gaining significant traction. Industry leaders such as 3M, GlaxoSmithKline, AstraZeneca, Novartis, Boehringer Ingelheim, Bespak, Propeller Health, Cohero Health, and Agilent Technologies are investing in sustainable propellants, connected technologies, and patient-centric solutions. Regional dynamics are shifting, with North America retaining dominance, Europe pushing environmental and cost regulations, and Asia-Pacific emerging as the fastest-growing region due to rising respiratory illness and pollution. Recent developments include inhaler cost caps, eco-friendly device initiatives, and the growth of generics. The inhalers market’s future will be defined by affordability, sustainability, and digital transformation—ensuring better outcomes for patients and new growth opportunities for industry leaders.
Published 22 September 2025

According to The Insight Partners – The market for inhalers, a vital support column in the treatment of respiratory diseases such as asthma and COPD, is being meaningfully transformed. Advances in device technology, sustainability, and regulatory burden are driving how inhalers are designed and utilized. Industry leaders 3M, Agilent Technologies, GlaxoSmithKline, Novartis, Propeller Health, Boehringer Ingelheim, Bespak, AstraZeneca, and Cohero Health are at the forefront.

Market Overview & Forecast (by 2031)

Worldwide CAGR (2025–2031): About 5.3% due to patient needs, regulatory changes, and device innovation.

Size of the market in 2023: Estimated to be mid-teen billions led by robust metered dose inhaler demand.

Billion, including smart and digital inhaler growth.

Get Sample PDF:- https://www.theinsightpartners.com/sample/TIPRE00021658

Key Trends & Insights

Increased use of smart/digital inhalers that enhance compliance and provide dosage feedback.

Pressure from pharma companies to minimize environmental footprint (propellant reformulations, reduced carbon footprint inhalers).

Regulatory pressure and policy efforts, such as price controls on inhalers in certain markets.

Metered dose inhalers (MDIs) continued to grow well; dry powder inhalers (DPIs) and digitally advanced devices picking up pace.

Increased uptake in emerging markets because of increased burden of respiratory diseases, air quality, and enhanced access to healthcare.

Market Leaders & Company Profiles

3M: Leading in device materials and propellant technology.

GlaxoSmithKline (GSK) & AstraZeneca: Global leaders in maintenance and rescue inhalers, investing in greener technologies.

Novartis: Involvement in smart inhalers and sensor-enabled devices.

Boehringer Ingelheim, Propeller Health, Bespak, Cohero Health: Concentrated on device development, patient compliance, and digital health integration.

Agilent Technologies: Offering key testing, quality, and support equipment for inhaler development.

Global & Regional Analysis

Global Dynamics

The world market for inhalers is growing steadily, with moderate adoption in conventional devices and faster adoption in digital and smart inhalers. Regulatory transformation and sustainability pressures are driving innovation.

Regional Breakdown

North America: Dominant market with high rates of advanced and digitally connected inhaler adoption.

Europe: Strong emphasis on sustainability, environmental regulation, and accessibility.

Asia-Pacific: Fastest-growing region, with rising respiratory disease, pollution, and access to healthcare.

Latin America, Middle East & Africa: Growth driven by growing awareness, distribution, and regulatory favor.

Market Size, Share & Forecast (by 2031)

As of 2031, the market for inhalers is anticipated to exhibit:

MDIs continuing to dominate, with DPIs and digital devices taking a growing share.

Firm uptake of connected inhaler technologies (sensors, mobile apps, adherence monitoring).

Product design influenced by environmental rules and cost-efficiency pressures.

Asia-Pacific to gain greater share of global market growth.

Recent News Highlights

Top firms unveiled plans to limit out-of-pocket prices on inhalers in core markets, enhancing accessibility.

Pharma giants are moving fast to switch to low-carbon propellants to meet environmental goals.

Some popular inhaler brands are shifting to generics, changing competitive dynamics.

Implications & Outlook

For patients, this translates to more affordable, environmentally friendly, and digitally enabled inhaler choices.

For industry players, investments in R&D for sustainability, smartness, and low-cost production are essential.

For healthcare systems and regulators, the test will be how to balance innovation, affordability, and environmental sustainability.

Get Buy Now:- https://www.theinsightpartners.com/buy/TIPRE00021658 

About Us:

The Insight Partners is a one-stop industry research provider of actionable intelligence. We help our clients get solutions to their research requirements through our syndicated and consulting research services. We specialize in semiconductor and electronics, aerospace and defense, automotive and transportation, biotechnology, healthcare IT, manuacturing and construction, medical devices, technology, media and telecommunications, and chemicals and materials.

Contact Us:


Other Industry News

Ready to start publishing

Sign Up today!